Business Combinations (Tables)

12 Months Ended

Sep. 29, 2018

The purchase price allocation is as follows:



Cash	$	107.2
Marketable securities	82.9
Accounts receivable	40.2
Inventory	120.0
Property, plant and equipment	44.1
Other assets and liabilities, net	11.9
Accounts payable and accrued expenses	(76.6		)
Deferred revenue	(11.2		)
Capital lease obligation	(25.2		)
Identifiable intangible assets:
Developed technology	736.0
In-process research and development	107.0
Distribution agreement	42.0
Customer relationships	35.0
Trade names	74.0
Deferred income taxes, net	(315.2		)
Goodwill	685.7
Purchase Price	$	1,657.8

Schedule of Pro Forma Information

The following unaudited pro forma information presents the combined financial results for the Company and Cynosure as if the acquisition of Cynosure had been completed at the beginning of the prior fiscal year, September 26, 2015 (the first day of fiscal 2016):



	Twelve Months Ended		Twelve Months Ended
	September 30, 2017		September 24, 2016
Revenue	$	3,241.4	$	3,244.6
Net income	$	768.5	$	252.3
Basic earnings per common share	$	2.75	$	0.90
Diluted earnings per common share	$	2.69	$	0.88